Home › Companies › CORCEPT THERAPEUTICS INC. › 2024-2025

CORCEPT THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CORCEPT THERAPEUTICS INC.’s Form 8-K, filed 2025-06-16 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 12Reported items
  • 371Asset managers
  • 4,327Fund votes
  • 2025-06-10Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CORCEPT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CORCEPT THERAPEUTICS INC.

These tallies are CORCEPT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORCEPT THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-10
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Gregg Alton 76,656,278---- 738,79914,932,062 Majority: yes
Elect Director: G. Leonard Baker, Jr. 74,929,739---- 2,465,33814,932,062 Majority: yes
Elect Director: Joseph K. Belanoff, M.D. 77,216,259---- 178,81814,932,062 Majority: yes
Elect Director: Gillian M. Cannon, Ph.D. 76,306,553---- 1,088,52414,932,062 Majority: yes
Elect Director: David L. Mahoney 62,676,355---- 14,718,72214,932,062 Majority: yes
Elect Director: Joshua M. Murray 76,980,464---- 414,61314,932,062 Majority: yes
Elect Director: Kimberly Park 70,542,361---- 6,852,71614,932,062 Majority: yes
Elect Director: Daniel N. Swisher, Jr. 76,564,863---- 830,21414,932,062 Majority: yes
Elect Director: James N. Wilson 75,426,472---- 1,968,60514,932,062 Majority: yes
Proposal 2 - The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified. 90,463,3591,488,132375,648 ---- Majority: yes
Proposal 3 - The compensation of named executive officers was approved, on an advisory basis. 72,914,2934,195,859284,923 --14,932,064 Majority: yes

Source: CORCEPT THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-16 — read the filing on EDGAR.

How asset managers voted at the CORCEPT THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 371 asset managers that disclosed a CORCEPT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CORCEPT THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement.

COMPENSATIONMajority of the votes cast: yes

Combines 15 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 72,914,293AGAINST: 4,195,859

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”): 72,914,293 for, 4,195,859 against, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 69% for, 4% against (73% of the company cast a for/against vote).

The 368 asset managers below cast 96% of the shares they voted on this item FOR (56,011,787 for, 2,336,078 against).

FOR 96%
FOR: 56,011,787 (95.9%)AGAINST: 2,336,078 (4.0%)ABSTAIN: 52,727 (0.1%)NOT VOTED: 1,097 (0.0%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock12,464,31232,145 00For
Vanguard10,127,8855,076 10For
Fidelity5,108,5440 00For
State Street4,398,3611,321 00For
GEODE CAPITAL MANAGEMENT, LLC2,128,4400 00For
Charles Schwab1,997,5970 00For
Dimensional1,411,8430 00For
Renaissance1,081,4630 00For
First Trust826,7530 00For
Northern Trust751,8170 00For
JUPITER ASSET MANAGEMENT LTD634,4470 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP598,6851,221 00For
Clearbridge Investments, LLC591,3110 00For
PRINCIPAL GLOBAL INVESTORS544,3280 00For
SEI486,3090 00For
Apollon Wealth Management, LLC460,0000 00For
Man Group plc426,5530 00For
MELLON INVESTMENTS Corp414,8560 00For
Cerity Partners LLC397,7720 00For
Legg Mason376,3740 00For
Aberdeen0369,285 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC359,8140 00For
JPMorgan348,1440 00For
Nuveen318,3620 00For
PUBLIC SECTOR PENSION INVESTMENT BOARD317,5680 00For

Showing the 25 largest of 368 asset managers. See all 368 in the interactive database.

2. To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 90,463,359AGAINST: 1,488,132

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Proposal 2 - The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified.”): 90,463,359 for, 1,488,132 against, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 86% for, 1% against (87% of the company cast a for/against vote).

The 110 asset managers below cast 99.6% of the shares they voted on this item FOR (32,389,230 for, 123,850 against).

FOR 99.5%
FOR: 32,389,230 (99.6%)AGAINST: 123,850 (0.4%)ABSTAIN: 14,142 (0.0%)
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm ” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,830,8715,071 00For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,687107 00For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust119,9570 00For
Aberdeen0114,453 00Against
American Century110,6880 00For

Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.

3. Election of Directors: Gregg Alton

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 76,656,278WITHHELD: 738,799

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Alton”): 76,656,278 for, 738,799 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 73% for, 0.8% withheld (74% of the company cast a for/withheld vote).

The 106 asset managers below cast 100% of the shares they voted on this item FOR (32,447,503 for, 0 against).

FOR 99.7%
FOR: 32,447,503 (99.8%)ABSTAIN: 76,797 (0.2%)
Largest asset managers voting on “Election of Directors: Gregg Alton” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,835,9420 10For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,7940 00For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust119,9570 00For
Aberdeen114,4530 00For
American Century110,6880 00For

Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.

4. Election of Directors: Joseph K. Belanoff, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 77,216,259WITHHELD: 178,818

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 77,216,259 for, 178,818 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 73% for, 0.2% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (32,472,295 for, 0 against).

FOR 99.9%
FOR: 32,472,295 (100.0%)ABSTAIN: 14,205 (0.0%)
Largest asset managers voting on “Election of Directors: Joseph K. Belanoff, M.D.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,835,9430 00For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,7320 620For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust119,9570 00For
Aberdeen114,4530 00For
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

5. Election of Directors: James N. Wilson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 75,426,472WITHHELD: 1,968,605

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: James N. Wilson”): 75,426,472 for, 1,968,605 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 72% for, 2% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (32,100,915 for, 0 against).

FOR 99%
FOR: 32,100,915 (98.8%)ABSTAIN: 385,585 (1.2%)
Largest asset managers voting on “Election of Directors: James N. Wilson” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,830,8710 5,0720For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,6870 1070For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle00 216,5660Abstain
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust116,3150 3,6420For
Aberdeen00 114,4530Abstain
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

6. Election of Directors: G. Leonard Baker, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 74,929,739WITHHELD: 2,465,338

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 74,929,739 for, 2,465,338 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 71% for, 2% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (32,038,262 for, 0 against).

FOR 99%
FOR: 32,038,262 (98.6%)ABSTAIN: 448,237 (1.4%)
Largest asset managers voting on “Election of Directors: G. Leonard Baker, Jr.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,830,8700 5,0730For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,6870 1070For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle00 216,5660Abstain
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust116,3150 3,6420For
Aberdeen00 114,4530Abstain
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

7. Election of Directors: Gillian M. Cannon, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 76,306,553WITHHELD: 1,088,524

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gillian M. Cannon, Ph.D.”): 76,306,553 for, 1,088,524 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 73% for, 1% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (32,454,460 for, 0 against).

FOR 99.9%
FOR: 32,454,460 (99.9%)ABSTAIN: 32,040 (0.1%)
Largest asset managers voting on “Election of Directors: Gillian M. Cannon, Ph.D.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,830,8720 5,0710For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,7940 00For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust116,3150 3,6420For
Aberdeen114,4530 00For
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

8. Election of Directors: David L. Mahoney

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD 19%
FOR: 62,676,355WITHHELD: 14,718,722

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: David L. Mahoney”): 62,676,355 for, 14,718,722 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 60% for, 14% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (26,037,453 for, 0 against).

FOR 80%ABSTAIN 20%
FOR: 26,037,453 (80.1%)ABSTAIN: 6,449,047 (19.9%)
Largest asset managers voting on “Election of Directors: David L. Mahoney” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,825,1800 10,7630For
BlackRock9,461,5550 00For
Fidelity1,655,8950 1,876,5100Abstain
State Street1,394,3280 8,4660For
Dimensional00 1,149,3530Abstain
Charles Schwab951,5450 00For
First Trust00 819,7940Abstain
Legg Mason366,2000 10,1740For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS00 234,8310Abstain
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust00 200,9600Abstain
Jackson National00 195,4790Abstain
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp00 155,7060Abstain
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya00 124,1550Abstain
Lincoln Financial59,9930 62,1990Abstain
Principal29,8630 90,5710Abstain
Bridge Builder Trust15,8370 104,1200Abstain
Aberdeen00 114,4530Abstain
American Century00 110,6880Abstain

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

9. Election of Directors: Joshua M. Murray

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 76,980,464WITHHELD: 414,613

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joshua M. Murray”): 76,980,464 for, 414,613 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 73% for, 0.4% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (32,472,355 for, 0 against).

FOR 99.9%
FOR: 32,472,355 (100.0%)ABSTAIN: 14,145 (0.0%)
Largest asset managers voting on “Election of Directors: Joshua M. Murray” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,835,9420 10For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,7940 00For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust119,9570 00For
Aberdeen114,4530 00For
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

10. Election of Directors: Kimberly Park

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 70,542,361WITHHELD: 6,852,716

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kimberly Park”): 70,542,361 for, 6,852,716 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 67% for, 7% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (30,327,266 for, 0 against).

FOR 93%
FOR: 30,327,266 (93.4%)ABSTAIN: 2,159,234 (6.6%)
Largest asset managers voting on “Election of Directors: Kimberly Park” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,830,8670 5,0760For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street11,9480 1,390,8460Abstain
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle00 216,5660Abstain
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI00 183,7830Abstain
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds00 150,0000Abstain
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial62,1990 59,9930For
Principal120,4340 00For
Bridge Builder Trust116,3150 3,6420For
Aberdeen114,4530 00For
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

11. Election of Directors: Daniel N. Swisher, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 76,564,863WITHHELD: 830,214

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 76,564,863 for, 830,214 withheld, per its Form 8-K filed 2025-06-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 105,113,000 outstanding shares: 73% for, 0.8% withheld (74% of the company cast a for/withheld vote).

The 105 asset managers below cast 100% of the shares they voted on this item FOR (32,405,562 for, 0 against).

FOR 99.7%
FOR: 32,405,562 (99.8%)ABSTAIN: 80,938 (0.2%)
Largest asset managers voting on “Election of Directors: Daniel N. Swisher, Jr.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard9,835,9420 10For
BlackRock9,461,5550 00For
Fidelity3,532,4050 00For
State Street1,402,7940 00For
Dimensional1,149,3530 00For
Charles Schwab951,5450 00For
First Trust819,7940 00For
Legg Mason376,3740 00For
TIAA310,9650 00For
BOSTON TRUST WALDEN FUNDS234,8310 00For
Equitable223,2610 00For
Columbia Threadneedle216,5660 00For
Janus Detroit Street Trust200,9600 00For
Jackson National195,4790 00For
SEI183,7830 00For
Royce168,5500 00For
MoA Funds Corp155,7060 00For
Franklin Custodian Funds150,0000 00For
Calamos138,0160 00For
Voya124,1550 00For
Lincoln Financial122,1920 00For
Principal120,4340 00For
Bridge Builder Trust119,9570 00For
Aberdeen114,4530 00For
American Century110,6880 00For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

12. DIRECTOR

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (6,316 for, 0 against).

FOR: 6,316 (100.0%)
Largest asset managers voting on “DIRECTOR” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Jackson Creek Investment Advisors LLC3,8610 00For
BOSUN ASSET MANAGEMENT, LLC2,3220 00For
Tidal Trust III1330 00For

Largest CORCEPT THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of CORCEPT THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 105,113,000 shares outstanding at the time of that meeting.

Top CORCEPT THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 11.89%
2Vanguard 9.64%
3Fidelity 4.86%
4State Street 4.19%
5GEODE CAPITAL MANAGEMENT, LLC 2.02%
6Charles Schwab 1.90%
7Dimensional 1.34%
8Renaissance 1.03%
9First Trust 0.79%
10Northern Trust 0.72%

Reported CORCEPT THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CORCEPT THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 13.97% 13F
Vanguard Group 9.50% 13F
INGALLS & SNYDER LLC 6.91% 13G
Joseph K. Belanoff 6.49% 13G
Renaissance Technologies LLC 5.48% 13G
G. Leonard Baker, Jr. 5.28% DEF14A
State Street 3.24% 13F
James N. Wilson 2.87% DEF14A
Geode Capital 2.15% 13F
Dimensional Fund Advisors 2.03% 13F

Percentages above are of 105,113,000 shares outstanding, as reported by CORCEPT THERAPEUTICS INC. on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORCEPT THERAPEUTICS INC.’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CORCEPT THERAPEUTICS INC.'s shareholder meeting held 2025-06-10, in the 2024-2025 proxy season, 371 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,327 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CORCEPT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-16.

CORCEPT THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.